David Funt, MD
Cardiovascular Disease · Boca Raton, FLNPI 1780671248
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Eli Lilly at 47.1% of the total. Reporting peaked in 2024 at $1,172 and has fallen 93.7% since, to $74 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 43 payments — averaging $52.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1K
- Astellas Pharma US Inc$297
- AbbVie$184
- Abbott$144
- Novo Nordisk$107
- Philips North America LLC$97
- plus $366 from 8 others
Across 486 payments — averaging $6058.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.2M
- Novartis$498K
- Boehringer Ingelheim International GmbH$291K
- Cleerly, Inc.$288K
- Modernatx, Inc.$200K
- Amgen$152K
- plus $322K from 8 others
What the payments were for
- Travel & lodging$74933%
- Food & beverage$1,21454%
- Education$29713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 12 | $1,065 |
| Astellas Pharma US Inc | 3 | $297 |
| AbbVie(2 entities) | 3 | $184 |
| Abbott | 1 | $144 |
| Novo Nordisk | 1 | $107 |
| Philips North America LLC | 3 | $97 |
| Novartis | 5 | $92 |
| Merz North America, Inc. | 2 | $74 |
| Amgen | 4 | $69 |
| Pfizer | 3 | $51 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $27 |
| Boston Scientific | 1 | $26 |
| AstraZeneca | 1 | $15 |
| Preventice Services, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$149
- Mitra Clip system$144
How this compares
$2,260 in reported general payments places this provider in the 45th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $14,312 |
| Ezetimibe | 28 | $591 |
| Rosuvastatin Calcium | 50 | $562 |
| Metoprolol Succinate | 29 | $481 |
| Atorvastatin Calcium | 29 | $389 |
| Losartan Potassium | 29 | $230 |
| Amlodipine Besylate | 47 | $216 |
| Metoprolol Tartrate | 16 | $88 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Boca Raton
- Seth BaumBoca Raton$517K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
- Neel PatelMaitland$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.